Structural basis for Ca 2+ activation of the heteromeric PKD1L3/PKD2L1 channel cDDP, like most chemotherapeutic drugs, is known to induce cell death by apoptosis. 10 Figure 3 shows that when cells ...
Intrapatient dose escalation to 800 mg/m2 pemetrexed is safe and feasible in patients with advanced non-small cell lung cancer (NSCLC) who have had prior chemotherapy No significant financial ...
For the first time, weekly cisplatin plus radiotherapy (CDDP+RT) has been shown to be not only less toxic than dosing once every three weeks but also achieves better outcomes in patients with ...
Navelbine (NVB) oral (o) with cisplatin (CDDP) as induction and concomitant to radiotherapy (RT): Final results of an international phase II trial in stage III non-small cell lung cancer (NSCLC) No ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback